Development of UHPLC-MS/MS Method for Indirubin-3′-Oxime Derivative as a Novel FLT3 Inhibitor and Pharmacokinetic Study in Rats
This study aimed to develop and validate a sensitive liquid chromatography-coupled tandem mass spectrometry method for the quantification of LDD-2614, an indirubin derivative and novel FLT3 inhibitor, in rat plasma. In addition, the developed analytical method was applied to observe the pharmacokine...
Main Authors: | Na Yoon Kim, Yong-Chul Kim, Yoon Gyoon Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-04-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/25/9/2039 |
Similar Items
-
Development of a UHPLC-MS/MS method for the quantification of ilaprazole enantiomers in rat plasma and its pharmacokinetic application
by: Fengting Ou, et al.
Published: (2020-12-01) -
Largazole Pharmacokinetics in Rats by LC-MS/MS
by: Mingming Yu, et al.
Published: (2014-03-01) -
LC-MS/MS Validation Analysis of Trastuzumab Using dSIL Approach for Evaluating Pharmacokinetics
by: Rohit H. Budhraja, et al.
Published: (2016-11-01) -
Rapid and sensitive analysis of cyclobenzaprine by LC–MS/MS: Application to a pharmacokinetic study of cyclobenzaprine in dog
by: Wenhong Yu, et al.
Published: (2014-04-01) -
Determination and pharmacokinetics study of oxyclozanide suspension in cattle by LC-MS/MS
by: Jili Zhang, et al.
Published: (2019-06-01)